Butorphanol Decreases Edema Following Carrageenan-Induced Paw Inflammation in Rats

Contemporary Topics in Laboratory Animal Science

Volumn 41, Issue 6, 2002, Pages 15-17

  Vachon, Pascal ^a   Moreau, Jean Pierre ^b  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b MDS Inc   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BUTORPHANOL; CARRAGEENAN; INDOMETACIN; NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; DOSE RESPONSE; DRUG COMBINATION; EDEMA; FEMALE; FOOT; HINDLIMB; INFLAMMATION; PATHOLOGY; RAT; SPRAGUE DAWLEY RAT;

ANALGESICS, OPIOID; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BUTORPHANOL; CARRAGEENAN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; EDEMA; FEMALE; FOOT; HINDLIMB; INDOMETHACIN; INFLAMMATION; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0036831255     PISSN: 10600558     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Winter, C. A., E. A. Risley, and G. W. Nuss. 1962. Carrageenin-induced edema in hind paw of the rat as an assay for antiinflammatory drugs. Proc. Soc. Exp. Biol. Med. 111:544-547.
2. Barber, A. and R. Gottschlich. 1992. Opioid agonists and antagonists: an evaluation of their peripheral actions in inflammation. Med. Res. Rev. 12:525-562.
3. Russell, N. J. W., A. Jamieson, T. S. Callen, et al. 1985. Peripheral opioid effects upon neurogenic extravasation and inflammation. Br. J. Pharmacol. 84:788P.
4. Flecknell, P. A. 1996. Laboratory animal anaesthesia. Academic Press, London.
5. Whiteley, P. E., and S. A. Dalrymple. 1998. Models of inflammation: carrageenan-induced paw edema in the rat. In S. J. Enna (ed.), Current protocols in pharmacology, vol. 1. John Wiley and Sons, New York.
6. Joris, J., A. Costello, R. Dubner, et al. 1990. Opiates suppress carrageenan-induced edema and hyperthermia at doses that inhibit hyperalgesia. Pain 43:95-105.
7. Pfeiffer, A. and A. Herz. 1984. Endocrine actions of opioids. Horm. Metabol. Res. 16:386-397.
8. Iyengar, S., H. S. Kim, and P. L. Wood. 1986. Effects of kappa opiate agonists on neurochemical and neuroendocrine indices: evidence for kappa receptor subtypes. Life Sci. 18:637-644.
9. Gonzalvez, M. L., M. V. Milanes, and M. L. Vargas. 1991. Effects of acute and chronic administration of mu- and delta-opioid agonists on the hypothalamic-pituitary-adrenocortical (HPA) axis in the rat. Eur. J. Pharmacol. 23:155-158.
10. Pfeiffer, A., G. Feuerstein, R. L. Zerbe, et al. 1983. μ-receptors mediate opioid cardiovascular effects at anterior hypothalamic sites through sympatho-adrenomedullary and parasympathetic pathways. Endocrinology 113:929-938.
11. May, C. N., C. J. Whitehead, K. E. Heslop, et al. 1989. Evidence that intravenous morphine stimulates central opiate receptors to increase sympatho-adrenal outflow and cause hypertension in conscious rabbits. Clin. Sci. (London) 76:431-437.
12. Laurent, S. and H. Schmitt. 1983. Central cardiovascular effects of κ agonists dynorphin-(1-13) and ethylketocyclazocine in the anaesthetized rat. Eur. J. Pharmacol. 96:165-169.
13. Ensinger, H., L. Hedler, B. Szabo, et al. 1986. Bremazocine causes sympatho-inhibition and hypotension in rabbits by activating peripheral kappa-receptors. J. Cardiovasc. Pharmacol. 8:470-475.
14. Spector, W. G. and D. A. Willoughby.1960. The enzymic inactivation of an adrenaline-like substance in inflammation. J. Path. Bact. 80:271-280.
15. Willoughby, D. A. and W. G. Spector. 1964. Adrenaline precursors in the inflammation reaction. J. Path. Bact. 88:159-166.
16. Iyengar, S., H. S. Kim, and P. L. Wood. 1986. Kappa opiate agonists modulate the hypothalamic-pituitary-adrenocortical axis in the rat. J. Pharmacol. Exp. Ther. 238:429-436.